DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights: Revenue ...
Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...
Smartwatches still can’t measure blood sugar on their own, but AI-powered CGMs are changing how glucose data is tracked and ...
Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...
Diabetes technology news has been off to a fast start this year. Here are some highlights of MedTech Dive’s coverage from ...
Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...
Eightco Holdings Inc. ("Eightco" or the "Company") today provided an update on its total holdings, highlighting its position ...
Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the commercial launch of its Omnipod 5 ...
Complete Invesco Nasdaq Free Cash Flow Achievers ETF funds overview by Barron's. View the QOWZ funds market news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results